Gainers

• Gelteq (NASDAQ:GELS) stock increased by 150.7% to $1.29 during Thursday's regular session. The company's market cap stands at $5.5 million.
• Propanc Biopharma (NASDAQ:PPCB) stock increased by 134.07% to $3.16. The market value of their outstanding shares is at $3.0 million.
• Adial Pharmaceuticals (NASDAQ:ADIL) stock increased by 43.98% to $3.11. The market value of their outstanding shares is at $4.6 million.
• Theriva Biologics (AMEX:TOVX) shares moved upwards by 37.33% to $0.33. The company's market cap stands at $11.1 million.
• Indaptus Therapeutics (NASDAQ:INDP) shares rose 31.42% to $3.22. The market value of their outstanding shares is at $277.4 million.
• Rafael Holdings (NYSE:RFL) shares increased by 19.1% to $2.12. The company's market cap stands at $92.5 million. As per the press release, Q3 earnings came out today.

Losers

• Atossa Therapeutics (NASDAQ:ATOS) shares decreased by 42.2% to $2.54 during Thursday's regular session. The company's market cap stands at $37.8 million.
• Purple Biotech (NASDAQ:PPBT) shares decreased by 34.46% to $1.94. The market value of their outstanding shares is at $2.7 million.
• Aditxt (NASDAQ:ADTX) shares decreased by 27.03% to $0.01.
• Humacyte (NASDAQ:HUMA) shares fell 24.26% to $1.01. The company's market cap stands at $297.5 million.
• BGM Group (NASDAQ:BGM) stock declined by 19.21% to $0.34. The company's market cap stands at $85.2 million.
• Valion Bio (NASDAQ:VBIO) stock decreased by 17.91% to $0.65. The market value of their outstanding shares is at $2.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.